Krystal Biotech Inc banner

Krystal Biotech Inc
SWB:4KB

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
SWB:4KB
Watchlist
Price: 241.2 EUR 6.68% Market Closed
Market Cap: €6.9B

Wall St Price Targets

4KB Price Targets Summary
Krystal Biotech Inc

Wall Street analysts forecast 4KB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 4KB is 276.55 EUR with a low forecast of 187.86 EUR and a high forecast of 362.44 EUR.

Lowest Forecast
Price Target
187.86 EUR
22% Downside
Average Forecast
Price Target
276.55 EUR
15% Upside
Highest Forecast
Price Target
362.44 EUR
50% Upside
Krystal Biotech Inc Competitors:
Price Targets
QNST
Quinstreet Inc
48% Upside
FAST
Fastenal Co
4% Upside
QTTB
Homology Medicines Inc
22% Upside

Revenue
Forecast

N/A
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Revenue over the next 3 years is 32%.

Gross Profit
Forecast

N/A
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Gross Profit over the next 3 years is 38%.

Operating Income
Forecast

N/A
Past Growth
56% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
56% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

The compound annual growth rate for Operating Income over the next 3 years is 56%.

Pre-Tax Income
Forecast

N/A
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.

Net Income
Forecast

N/A
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat
N/A
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat

The compound annual growth rate for Net Income over the next 3 years is 35%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 4KB's stock price target?
Price Target
276.55 EUR

According to Wall Street analysts, the average 1-year price target for 4KB is 276.55 EUR with a low forecast of 187.86 EUR and a high forecast of 362.44 EUR.

What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
32%

The compound annual growth rate for Revenue over the next 3 years is 32%.

What is the Gross Profit forecast for Krystal Biotech Inc?
Projected CAGR
38%

The compound annual growth rate for Gross Profit over the next 3 years is 38%.

What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
56%

The compound annual growth rate for Operating Income over the next 3 years is 56%.

What is the Pre-Tax Income forecast for Krystal Biotech Inc?
Projected CAGR
44%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.

What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
35%

The compound annual growth rate for Net Income over the next 3 years is 35%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett